nodes	percent_of_prediction	percent_of_DWPC	metapath
Dopamine—DBH—adrenal medulla—adrenal gland cancer	0.128	0.263	CbGeAlD
Dopamine—DBH—sympathetic nervous system—adrenal gland cancer	0.0849	0.175	CbGeAlD
Dopamine—SLC6A2—sympathetic nervous system—adrenal gland cancer	0.0323	0.0666	CbGeAlD
Dopamine—HTR7—sympathetic nervous system—adrenal gland cancer	0.0312	0.0642	CbGeAlD
Dopamine—HTR7—vein—adrenal gland cancer	0.0291	0.06	CbGeAlD
Dopamine—Masoprocol—IGF1R—adrenal gland cancer	0.0284	0.904	CrCbGaD
Dopamine—CYP2C19—urine—adrenal gland cancer	0.0167	0.0343	CbGeAlD
Dopamine—CYP1A2—urine—adrenal gland cancer	0.0136	0.028	CbGeAlD
Dopamine—CYP2C9—urine—adrenal gland cancer	0.0129	0.0266	CbGeAlD
Dopamine—DBH—adrenal cortex—adrenal gland cancer	0.0123	0.0254	CbGeAlD
Dopamine—CYP2D6—urine—adrenal gland cancer	0.0097	0.02	CbGeAlD
Dopamine—DBH—adrenal gland—adrenal gland cancer	0.00889	0.0183	CbGeAlD
Dopamine—COMT—adrenal cortex—adrenal gland cancer	0.00651	0.0134	CbGeAlD
Dopamine—COMT—gonad—adrenal gland cancer	0.00539	0.0111	CbGeAlD
Dopamine—COMT—cardiac atrium—adrenal gland cancer	0.00539	0.0111	CbGeAlD
Dopamine—COMT—pituitary gland—adrenal gland cancer	0.00526	0.0108	CbGeAlD
Dopamine—MAOB—adrenal cortex—adrenal gland cancer	0.00507	0.0104	CbGeAlD
Dopamine—COMT—adrenal gland—adrenal gland cancer	0.0047	0.00968	CbGeAlD
Dopamine—ADRB1—cardiac atrium—adrenal gland cancer	0.00456	0.0094	CbGeAlD
Dopamine—SLC22A3—gonad—adrenal gland cancer	0.00453	0.00934	CbGeAlD
Dopamine—MAOA—adrenal cortex—adrenal gland cancer	0.00432	0.0089	CbGeAlD
Dopamine—MAOB—cardiac atrium—adrenal gland cancer	0.00419	0.00863	CbGeAlD
Dopamine—MAOB—pituitary gland—adrenal gland cancer	0.00409	0.00843	CbGeAlD
Dopamine—SLC22A5—adrenal cortex—adrenal gland cancer	0.00398	0.0082	CbGeAlD
Dopamine—SLC22A3—adrenal gland—adrenal gland cancer	0.00395	0.00814	CbGeAlD
Dopamine—SLC6A2—gonad—adrenal gland cancer	0.00389	0.008	CbGeAlD
Dopamine—HTR7—gonad—adrenal gland cancer	0.00374	0.00771	CbGeAlD
Dopamine—MAOB—adrenal gland—adrenal gland cancer	0.00366	0.00753	CbGeAlD
Dopamine—MAOA—cardiac atrium—adrenal gland cancer	0.00358	0.00736	CbGeAlD
Dopamine—MAOA—pituitary gland—adrenal gland cancer	0.00349	0.00719	CbGeAlD
Dopamine—DRD2—pituitary gland—adrenal gland cancer	0.00345	0.00712	CbGeAlD
Dopamine—HTR1A—adrenal gland—adrenal gland cancer	0.00342	0.00704	CbGeAlD
Dopamine—SLC6A2—adrenal gland—adrenal gland cancer	0.00339	0.00698	CbGeAlD
Dopamine—SLC22A5—cardiac atrium—adrenal gland cancer	0.00329	0.00678	CbGeAlD
Dopamine—HTR7—adrenal gland—adrenal gland cancer	0.00326	0.00672	CbGeAlD
Dopamine—SLC22A5—pituitary gland—adrenal gland cancer	0.00322	0.00663	CbGeAlD
Dopamine—MAOA—adrenal gland—adrenal gland cancer	0.00312	0.00643	CbGeAlD
Dopamine—Mesalazine—PTGS2—adrenal gland cancer	0.00302	0.096	CrCbGaD
Dopamine—SLC22A5—adrenal gland—adrenal gland cancer	0.00287	0.00592	CbGeAlD
Dopamine—HTR7—Signaling Pathways—TSHR—adrenal gland cancer	0.000221	0.000457	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000219	0.000454	CbGpPWpGaD
Dopamine—DRD1—Circadian rythm related genes—TP53—adrenal gland cancer	0.000218	0.000452	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—CDC42—adrenal gland cancer	0.000218	0.00045	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—GNAS—adrenal gland cancer	0.000217	0.00045	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—SPRY2—adrenal gland cancer	0.000217	0.000448	CbGpPWpGaD
Dopamine—DRD1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000216	0.000446	CbGpPWpGaD
Dopamine—DRD3—Circadian rythm related genes—TP53—adrenal gland cancer	0.000215	0.000446	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—GNRH1—adrenal gland cancer	0.000213	0.000441	CbGpPWpGaD
Dopamine—MAOB—Metabolism—GNAS—adrenal gland cancer	0.000213	0.000441	CbGpPWpGaD
Dopamine—DRD3—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000213	0.000441	CbGpPWpGaD
Dopamine—HTR1A—GPCR ligand binding—POMC—adrenal gland cancer	0.000211	0.000437	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—TSHR—adrenal gland cancer	0.000211	0.000437	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—GNRH1—adrenal gland cancer	0.00021	0.000436	CbGpPWpGaD
Dopamine—MAOB—Metabolism—ABCB1—adrenal gland cancer	0.000209	0.000433	CbGpPWpGaD
Dopamine—DRD5—GPCR downstream signaling—POMC—adrenal gland cancer	0.000209	0.000432	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—GNAS—adrenal gland cancer	0.000208	0.00043	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000208	0.00043	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—MEN1—adrenal gland cancer	0.000207	0.000429	CbGpPWpGaD
Dopamine—DRD1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000206	0.000427	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—PRKACA—adrenal gland cancer	0.000205	0.000425	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—SDHB—adrenal gland cancer	0.000205	0.000424	CbGpPWpGaD
Dopamine—DRD3—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000203	0.000421	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—SDHB—adrenal gland cancer	0.000203	0.000421	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000199	0.000411	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—MEN1—adrenal gland cancer	0.000199	0.000411	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—CDC42—adrenal gland cancer	0.000196	0.000405	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—SPRY2—adrenal gland cancer	0.000195	0.000404	CbGpPWpGaD
Dopamine—CYP1A2—Biological oxidations—POMC—adrenal gland cancer	0.000194	0.000402	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000194	0.000401	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—CDC42—adrenal gland cancer	0.000193	0.0004	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—SPRY2—adrenal gland cancer	0.000192	0.000398	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—GNRH1—adrenal gland cancer	0.000192	0.000397	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—MED12—adrenal gland cancer	0.000191	0.000396	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—TSHR—adrenal gland cancer	0.00019	0.000393	CbGpPWpGaD
Dopamine—DRD5—Signaling by GPCR—POMC—adrenal gland cancer	0.00019	0.000393	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—TSHR—adrenal gland cancer	0.000188	0.000388	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000187	0.000388	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—GNAS—adrenal gland cancer	0.000187	0.000387	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000185	0.000384	CbGpPWpGaD
Dopamine—DRD2—GPCR ligand binding—POMC—adrenal gland cancer	0.000185	0.000384	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000185	0.000384	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—GNAS—adrenal gland cancer	0.000185	0.000382	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—GNRH1—adrenal gland cancer	0.000183	0.00038	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—GNAS—adrenal gland cancer	0.00018	0.000373	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—MEN1—adrenal gland cancer	0.000179	0.00037	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—MED12—adrenal gland cancer	0.000178	0.000369	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000177	0.000367	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—ABCB1—adrenal gland cancer	0.000177	0.000366	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—MEN1—adrenal gland cancer	0.000176	0.000365	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—CDC42—adrenal gland cancer	0.000176	0.000365	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000175	0.000363	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—SPRY2—adrenal gland cancer	0.000175	0.000363	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000174	0.000361	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—CDC42—adrenal gland cancer	0.000174	0.00036	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—SDHB—adrenal gland cancer	0.000174	0.000359	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—TSHR—adrenal gland cancer	0.000171	0.000354	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—CDC42—adrenal gland cancer	0.000168	0.000349	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—GNAS—adrenal gland cancer	0.000168	0.000348	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—IGF2—adrenal gland cancer	0.000168	0.000347	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—SPRY2—adrenal gland cancer	0.000168	0.000347	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—GNAS—adrenal gland cancer	0.000166	0.000344	CbGpPWpGaD
Dopamine—MAOA—Metabolism—PRKACA—adrenal gland cancer	0.000165	0.000342	CbGpPWpGaD
Dopamine—DRD2—Circadian rythm related genes—TP53—adrenal gland cancer	0.000165	0.000341	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—TSHR—adrenal gland cancer	0.000163	0.000338	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000163	0.000337	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—IGF1R—adrenal gland cancer	0.000162	0.000336	CbGpPWpGaD
Dopamine—HTR7—GPCR downstream signaling—POMC—adrenal gland cancer	0.000161	0.000333	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—GNRH1—adrenal gland cancer	0.000161	0.000333	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—GNAS—adrenal gland cancer	0.000161	0.000333	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—MEN1—adrenal gland cancer	0.000161	0.000333	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.00016	0.000331	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—PRKACA—adrenal gland cancer	0.000158	0.000328	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000156	0.000322	CbGpPWpGaD
Dopamine—DRD4—GPCR downstream signaling—POMC—adrenal gland cancer	0.000154	0.000319	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—MEN1—adrenal gland cancer	0.000154	0.000318	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—PRKACA—adrenal gland cancer	0.000152	0.000314	CbGpPWpGaD
Dopamine—COMT—Metabolism—POMC—adrenal gland cancer	0.000151	0.000313	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—CDC42—adrenal gland cancer	0.000148	0.000306	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—SPRY2—adrenal gland cancer	0.000147	0.000305	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—POMC—adrenal gland cancer	0.000146	0.000303	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—RRM1—adrenal gland cancer	0.000144	0.000297	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—SDHD—adrenal gland cancer	0.000144	0.000297	CbGpPWpGaD
Dopamine—MAOB—Metabolism—POMC—adrenal gland cancer	0.000144	0.000297	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—TSHR—adrenal gland cancer	0.000144	0.000297	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—GNAS—adrenal gland cancer	0.000141	0.000293	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—POMC—adrenal gland cancer	0.00014	0.00029	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—TERT—adrenal gland cancer	0.00014	0.000289	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—PRKACA—adrenal gland cancer	0.00014	0.000289	CbGpPWpGaD
Dopamine—DRD1—GPCR downstream signaling—POMC—adrenal gland cancer	0.000139	0.000287	CbGpPWpGaD
Dopamine—DRD3—GPCR downstream signaling—POMC—adrenal gland cancer	0.000137	0.000283	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000137	0.000283	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—PRKACA—adrenal gland cancer	0.000136	0.000282	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—MEN1—adrenal gland cancer	0.000135	0.000279	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—PRKACA—adrenal gland cancer	0.000135	0.000279	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—CDC42—adrenal gland cancer	0.000134	0.000278	CbGpPWpGaD
Dopamine—MAOA—Metabolism—GNAS—adrenal gland cancer	0.000134	0.000277	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—RRM1—adrenal gland cancer	0.000132	0.000273	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—SDHD—adrenal gland cancer	0.000132	0.000273	CbGpPWpGaD
Dopamine—MAOA—Metabolism—ABCB1—adrenal gland cancer	0.000131	0.000272	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—SDHD—adrenal gland cancer	0.000131	0.000271	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—RRM1—adrenal gland cancer	0.000131	0.000271	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—PRKACA—adrenal gland cancer	0.00013	0.000269	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—IGF2—adrenal gland cancer	0.000129	0.000268	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CDC42—adrenal gland cancer	0.000129	0.000266	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—GNAS—adrenal gland cancer	0.000128	0.000266	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—POMC—adrenal gland cancer	0.000126	0.000261	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—IGF1R—adrenal gland cancer	0.000125	0.000259	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—POMC—adrenal gland cancer	0.000125	0.000258	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—POMC—adrenal gland cancer	0.000124	0.000257	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—IGF2—adrenal gland cancer	0.000124	0.000256	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—GNAS—adrenal gland cancer	0.000123	0.000254	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—PRKACA—adrenal gland cancer	0.000123	0.000254	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—BAD—adrenal gland cancer	0.000122	0.000252	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—POMC—adrenal gland cancer	0.000121	0.000251	CbGpPWpGaD
Dopamine—COMT—Metabolism—PTGS2—adrenal gland cancer	0.000121	0.00025	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—IGF1R—adrenal gland cancer	0.00012	0.000248	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—POMC—adrenal gland cancer	0.000119	0.000247	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000117	0.000243	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CDC42—adrenal gland cancer	0.000116	0.00024	CbGpPWpGaD
Dopamine—MAOB—Metabolism—PTGS2—adrenal gland cancer	0.000114	0.000237	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CDC42—adrenal gland cancer	0.000114	0.000236	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—POMC—adrenal gland cancer	0.000113	0.000235	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—GNAS—adrenal gland cancer	0.000113	0.000234	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—POMC—adrenal gland cancer	0.000112	0.000232	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—RRM1—adrenal gland cancer	0.000112	0.000232	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—SDHD—adrenal gland cancer	0.000112	0.000232	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—IGF2—adrenal gland cancer	0.000112	0.000231	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—ABCB1—adrenal gland cancer	0.000111	0.00023	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—BRAF—adrenal gland cancer	0.000111	0.000229	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—GNAS—adrenal gland cancer	0.000111	0.000229	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—IGF2—adrenal gland cancer	0.00011	0.000228	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—GNAS—adrenal gland cancer	0.000109	0.000226	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—POMC—adrenal gland cancer	0.000108	0.000224	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000108	0.000223	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—TERT—adrenal gland cancer	0.000108	0.000223	CbGpPWpGaD
Dopamine—DRD5—Signaling by GPCR—EGFR—adrenal gland cancer	0.000107	0.000222	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—MED12—adrenal gland cancer	0.000107	0.000222	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—IGF1R—adrenal gland cancer	0.000106	0.00022	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—GNAS—adrenal gland cancer	0.000105	0.000218	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—POMC—adrenal gland cancer	0.000105	0.000217	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CDC42—adrenal gland cancer	0.000104	0.000215	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—ABCB1—adrenal gland cancer	0.000103	0.000214	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—TERT—adrenal gland cancer	0.000103	0.000213	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—PRKACA—adrenal gland cancer	0.000103	0.000213	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—IGF2—adrenal gland cancer	0.0001	0.000208	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CDC42—adrenal gland cancer	9.95e-05	0.000206	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—GNAS—adrenal gland cancer	9.94e-05	0.000206	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—MED12—adrenal gland cancer	9.85e-05	0.000204	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—MED12—adrenal gland cancer	9.76e-05	0.000202	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—IGF1R—adrenal gland cancer	9.69e-05	0.000201	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—PTGS2—adrenal gland cancer	9.69e-05	0.0002	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—IGF2—adrenal gland cancer	9.59e-05	0.000199	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	9.57e-05	0.000198	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—POMC—adrenal gland cancer	9.51e-05	0.000197	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—GNAS—adrenal gland cancer	9.51e-05	0.000197	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—BAD—adrenal gland cancer	9.37e-05	0.000194	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—TERT—adrenal gland cancer	9.28e-05	0.000192	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—IGF1R—adrenal gland cancer	9.27e-05	0.000192	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—TERT—adrenal gland cancer	9.16e-05	0.00019	CbGpPWpGaD
Dopamine—MAOA—Metabolism—POMC—adrenal gland cancer	9.01e-05	0.000186	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—BAD—adrenal gland cancer	8.97e-05	0.000186	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CDC42—adrenal gland cancer	8.74e-05	0.000181	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	8.73e-05	0.000181	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—POMC—adrenal gland cancer	8.64e-05	0.000179	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—BRAF—adrenal gland cancer	8.53e-05	0.000177	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—IGF2—adrenal gland cancer	8.42e-05	0.000174	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—GNAS—adrenal gland cancer	8.35e-05	0.000173	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—TERT—adrenal gland cancer	8.34e-05	0.000173	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—MED12—adrenal gland cancer	8.34e-05	0.000173	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—POMC—adrenal gland cancer	8.27e-05	0.000171	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—EGFR—adrenal gland cancer	8.27e-05	0.000171	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—BRAF—adrenal gland cancer	8.17e-05	0.000169	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—IGF1R—adrenal gland cancer	8.14e-05	0.000169	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—BAD—adrenal gland cancer	8.08e-05	0.000167	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—CTNNB1—adrenal gland cancer	8e-05	0.000166	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—TERT—adrenal gland cancer	7.98e-05	0.000165	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—BAD—adrenal gland cancer	7.97e-05	0.000165	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—EGFR—adrenal gland cancer	7.91e-05	0.000164	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PRKACA—adrenal gland cancer	7.81e-05	0.000162	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	7.63e-05	0.000158	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—POMC—adrenal gland cancer	7.62e-05	0.000158	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	7.46e-05	0.000154	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—POMC—adrenal gland cancer	7.44e-05	0.000154	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—BRAF—adrenal gland cancer	7.35e-05	0.000152	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—POMC—adrenal gland cancer	7.35e-05	0.000152	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—BAD—adrenal gland cancer	7.26e-05	0.00015	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—BRAF—adrenal gland cancer	7.25e-05	0.00015	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	7.18e-05	0.000149	CbGpPWpGaD
Dopamine—MAOA—Metabolism—PTGS2—adrenal gland cancer	7.18e-05	0.000149	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—EGFR—adrenal gland cancer	7.13e-05	0.000147	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PRKACA—adrenal gland cancer	7.12e-05	0.000147	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—POMC—adrenal gland cancer	7.1e-05	0.000147	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—EGFR—adrenal gland cancer	7.03e-05	0.000146	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—TERT—adrenal gland cancer	7.01e-05	0.000145	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	6.96e-05	0.000144	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—BAD—adrenal gland cancer	6.94e-05	0.000144	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—POMC—adrenal gland cancer	6.69e-05	0.000139	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—BRAF—adrenal gland cancer	6.61e-05	0.000137	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—EGFR—adrenal gland cancer	6.41e-05	0.000133	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—POMC—adrenal gland cancer	6.4e-05	0.000133	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—EGFR—adrenal gland cancer	6.33e-05	0.000131	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—GNAS—adrenal gland cancer	6.33e-05	0.000131	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—BRAF—adrenal gland cancer	6.32e-05	0.000131	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—ABCB1—adrenal gland cancer	6.21e-05	0.000129	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—CTNNB1—adrenal gland cancer	6.17e-05	0.000128	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—EGFR—adrenal gland cancer	6.13e-05	0.000127	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—BAD—adrenal gland cancer	6.1e-05	0.000126	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PRKACA—adrenal gland cancer	6.09e-05	0.000126	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—PTGS2—adrenal gland cancer	6.07e-05	0.000126	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	5.95e-05	0.000123	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CTNNB1—adrenal gland cancer	5.9e-05	0.000122	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—GNAS—adrenal gland cancer	5.82e-05	0.000121	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—GNAS—adrenal gland cancer	5.77e-05	0.00012	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	5.71e-05	0.000118	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—ABCB1—adrenal gland cancer	5.66e-05	0.000117	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—PTGS2—adrenal gland cancer	5.66e-05	0.000117	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—POMC—adrenal gland cancer	5.62e-05	0.000116	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—BRAF—adrenal gland cancer	5.55e-05	0.000115	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—EGFR—adrenal gland cancer	5.38e-05	0.000111	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—TP53—adrenal gland cancer	5.32e-05	0.00011	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CTNNB1—adrenal gland cancer	5.31e-05	0.00011	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CTNNB1—adrenal gland cancer	5.24e-05	0.000109	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—GNAS—adrenal gland cancer	4.93e-05	0.000102	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—EGFR—adrenal gland cancer	4.88e-05	0.000101	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—ABCB1—adrenal gland cancer	4.84e-05	0.0001	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CTNNB1—adrenal gland cancer	4.78e-05	9.89e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—EGFR—adrenal gland cancer	4.68e-05	9.68e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CTNNB1—adrenal gland cancer	4.57e-05	9.46e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—POMC—adrenal gland cancer	4.26e-05	8.82e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—EGFR—adrenal gland cancer	4.21e-05	8.71e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—EGFR—adrenal gland cancer	4.15e-05	8.6e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—TP53—adrenal gland cancer	4.1e-05	8.49e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CTNNB1—adrenal gland cancer	4.01e-05	8.3e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—TP53—adrenal gland cancer	3.93e-05	8.13e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—POMC—adrenal gland cancer	3.92e-05	8.12e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—POMC—adrenal gland cancer	3.89e-05	8.05e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—EGFR—adrenal gland cancer	3.78e-05	7.83e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—EGFR—adrenal gland cancer	3.62e-05	7.49e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—TP53—adrenal gland cancer	3.53e-05	7.32e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—TP53—adrenal gland cancer	3.49e-05	7.22e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PTGS2—adrenal gland cancer	3.4e-05	7.04e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—POMC—adrenal gland cancer	3.32e-05	6.88e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—EGFR—adrenal gland cancer	3.18e-05	6.58e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—TP53—adrenal gland cancer	3.18e-05	6.58e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	3.13e-05	6.47e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PTGS2—adrenal gland cancer	3.1e-05	6.42e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—TP53—adrenal gland cancer	3.04e-05	6.29e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—TP53—adrenal gland cancer	2.67e-05	5.52e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PTGS2—adrenal gland cancer	2.65e-05	5.48e-05	CbGpPWpGaD
